Huons Co. Ltd (243070) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.028x

Based on the latest financial reports, Huons Co. Ltd (243070) has a cash flow conversion efficiency ratio of 0.028x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩10.92 Billion ≈ $7.40 Million USD) by net assets (₩395.25 Billion ≈ $267.86 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Huons Co. Ltd - Cash Flow Conversion Efficiency Trend (2016–2024)

This chart illustrates how Huons Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 243070 total liabilities for a breakdown of total debt and financial obligations.

Huons Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Huons Co. Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Context Therapeutics Inc
NASDAQ:CNTX
-0.090x
EMS Limited
NSE:EMSLIMITED
-0.031x
Xiongan Kerong Environment Technology Co Ltd
SHE:300152
-0.004x
BEXIMCO PHARMA.GDR REGS 1
F:R2WA
N/A
Kejuruteraan Asastera Bhd
KLSE:0193
-0.273x
Senseonics Holdings, Inc. Common Stock
NYSE MKT:SENS
-0.202x
Atrium Therapeutics, Inc. Common Stock
NASDAQ:RNA
-0.093x
Eastern Media International Corp
TW:2614
0.080x

Annual Cash Flow Conversion Efficiency for Huons Co. Ltd (2016–2024)

The table below shows the annual cash flow conversion efficiency of Huons Co. Ltd from 2016 to 2024. For the full company profile with market capitalisation and key ratios, see 243070 market cap overview.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 ₩345.97 Billion
≈ $234.46 Million
₩52.56 Billion
≈ $35.62 Million
0.152x -3.74%
2023-12-31 ₩330.41 Billion
≈ $223.92 Million
₩52.14 Billion
≈ $35.34 Million
0.158x +39.22%
2022-12-31 ₩282.46 Billion
≈ $191.42 Million
₩32.02 Billion
≈ $21.70 Million
0.113x -45.74%
2021-12-31 ₩266.09 Billion
≈ $180.33 Million
₩55.59 Billion
≈ $37.67 Million
0.209x +7.28%
2020-12-31 ₩238.80 Billion
≈ $161.83 Million
₩46.51 Billion
≈ $31.52 Million
0.195x -10.06%
2019-12-31 ₩194.52 Billion
≈ $131.82 Million
₩42.12 Billion
≈ $28.54 Million
0.217x +69.29%
2018-12-31 ₩163.27 Billion
≈ $110.64 Million
₩20.88 Billion
≈ $14.15 Million
0.128x -48.05%
2017-12-31 ₩122.69 Billion
≈ $83.15 Million
₩30.21 Billion
≈ $20.47 Million
0.246x -46.72%
2016-12-31 ₩93.88 Billion
≈ $63.62 Million
₩43.38 Billion
≈ $29.40 Million
0.462x --

About Huons Co. Ltd

KQ:243070 Korea Drug Manufacturers - Specialty & Generic
Market Cap
$208.46 Million
₩307.61 Billion KRW
Market Cap Rank
#16388 Global
#682 in Korea
Share Price
₩26400.00
Change (1 day)
-1.12%
52-Week Range
₩24750.00 - ₩32050.00
All Time High
₩66595.39
About

Huons Co., Ltd. provides medical solutions for human health in Korea and internationally. The company offers oral solid form drugs, including circulatory system, metabolic, antipyretic, analgesic, anti-inflammatory, musculoskeletal system, digestive system, antihistamine, respiratory system, anti-coagulant, antiviral, central nervous system, antibiotic, well-being, urogenital system, and other ch… Read more